Characteristics of antitumour activity of cepharanthin against a human adenosquamous cell carcinoma cell line
Authors:
- K. HaradaK. Harada
- T. BandoTBT. Bando
- H. YoshidaHYH. Yoshida
- M. SatoMSM. Sato
- 1 December 2001
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 37 (8) , 643-651
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 geneCancer Letters, 1997
- Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.Proceedings of the National Academy of Sciences, 1995
- Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminusCell, 1995
- Effects of hyperthermia and cepharanthin on adriamycin accumulation with changes in extracellular pHInternational Journal of Hyperthermia, 1995
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.Journal of Cell Biology, 1992
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Inhibition of interferon secretion by vinblastineJournal of Cell Biology, 1975
- Synthesis of d1-cepharanthineTetrahedron Letters, 1967